Načítá se...
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
BACKGROUND: Endometrial cancer is one of the most common gynaecological cancers in developed countries. Treatment of advanced endometrial cancer usually involves radiotherapy, chemotherapy, endocrine therapy or a combination of these. However, survival outcomes are poor in advanced or metastatic dis...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2019
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6953296/ https://ncbi.nlm.nih.gov/pubmed/31588998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012160.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|